MedTrace Logo

Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome

NCT06244433 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 650

Last updated 2026-05-08

No results posted yet for this study

Summary

This is a multicenter genetic study aimed at identifying new genes/variants associated with sudden infant death syndrome (SIDS) based on whole-genome sequencing of family trios

Conditions

  • Sudden Infant Death
  • Sudden Unexplained Infant Death

Interventions

GENETIC

whole genome sequencing

Study of all coding and non-coding sequences in the genome to identify pathogenic allelic variants

Sponsors & Collaborators

  • AXA Assurances VIE Mutuelle

    collaborator UNKNOWN

  • Institut du Thorax

    collaborator UNKNOWN

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Fleur Lorton · Nantes University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-27
Primary Completion
2026-08-27
Completion
2027-10-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06244433 on ClinicalTrials.gov